Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Ampliphi Biosciences Corp (APHB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,640
  • Shares Outstanding, K 33,469
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,110 K
  • 60-Month Beta 2.82
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.10
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.44
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/21/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.11
  • Number of Estimates 1
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +42.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.28 +13.13%
on 04/22/19
0.44 -28.56%
on 05/08/19
+0.03 (+9.17%)
since 04/09/19
3-Month
0.24 +32.46%
on 02/12/19
0.44 -28.56%
on 05/08/19
+0.07 (+27.16%)
since 02/08/19
52-Week
0.15 +111.93%
on 12/18/18
1.37 -76.80%
on 10/02/18
-0.77 (-70.83%)
since 05/09/18

Most Recent Stories

More News
C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today...

APHB : 0.32 (-20.33%)
C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today...

APHB : 0.32 (-20.33%)
AmpliPhi Biosciences Announces Stockholder Approval of Business Combination with C3J Therapeutics

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections,...

APHB : 0.32 (-20.33%)
AmpliPhi Biosciences Reports First Quarter 2019 Financial Results and Business Highlights

--$10.0 million of new capital to be invested in combined company

APHB : 0.32 (-20.33%)
Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation

AmpliPhi Biosciences Corporation (APHB)

CCC : 13.33 (+0.23%)
TISA : 0.85 (unch)
SXCP : 11.42 (+1.42%)
MYND : 1.16 (+2.56%)
APHB : 0.32 (-20.33%)
DVA : 49.60 (+1.49%)
FLKS : 0.40 (-2.42%)
SXC : 8.02 (+1.39%)
C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage

C3J Therapeutics, Inc. (C3J) a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials based on bacteriophage, today announced that the United...

APHB : 0.32 (-20.33%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of AmpliPhi Biosciences Corporation - APHB

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors...

APHB : 0.32 (-20.33%)
AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights

--$10.0 million of new capital will be invested in combined company to be re-named Armata Pharmaceuticals

APHB : 0.32 (-20.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade APHB with:

Business Summary

AmpliPhi Biosciences Corporation, formerly known as Targeted Genetics Corporation, is a biotechnology company which develops anti-bacterial solutions for the treatment of gram negative bacterial infections that are often resistant to existing antibiotic treatments. AmpliPhi Biosciences Corporation is...

See More

Key Turning Points

2nd Resistance Point 0.38
1st Resistance Point 0.35
Last Price 0.32
1st Support Level 0.30
2nd Support Level 0.28

See More

52-Week High 1.37
Fibonacci 61.8% 0.90
Fibonacci 50% 0.76
Fibonacci 38.2% 0.62
Last Price 0.32
52-Week Low 0.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar